ALHC vs CLOV: stock comparison and AI forecast
Alignment Healthcare, Inc. (ALHC) and Clover Health Investments, Corp. /De (CLOV) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALHC Alignment Healthcare, Inc.
- Price
- $7.00 -63.7% · 6M
- Market Cap
- $1.45B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
CLOV Clover Health Investments, Corp. /De
- Price
- $4.31 +62.6% · 6M
- Market Cap
- $2.29B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- CLOV is 1.6 times larger than ALHC by market capitalization ($2.29B against $1.45B).
- Over the last six months CLOV returned +62.6% and ALHC -63.7%.
- ALHC carries 3.68 times debt per unit of equity, against 0.91 times for CLOV.
- Both companies share the SEC industry classification Hospital & Medical Service Plans.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALHC | CLOV |
|---|---|---|
| Market Cap | $1.45B | $2.29B |
| P/B Ratio | 5.24x | 6.08x |
| EPS | $-0.06 | $-0.10 |
| Book Value/Share | $1.34 | $0.71 |
| Revenue/Share | $23.82 | $4.66 |
| FCF/Share | $0.37 | $0.14 |
Profitability & Margins
| Metric | ALHC | CLOV |
|---|---|---|
| ROIC | 7.2% | -4.6% |
| Operating Margin | 0.9% | -0.7% |
| EBT Margin | 0.6% | -0.8% |
| Tax Rate | -7.3% | – |
Financial Health
| Metric | ALHC | CLOV |
|---|---|---|
| Current Ratio | 1.71x | 1.50x |
| D/E Ratio | 3.68x | 0.91x |
| Financial Leverage | 4.68x | 1.91x |
| Interest Coverage | – | -4115.3x |
| Working Capital | $489M | $162M |
Cash Flow
| Metric | ALHC | CLOV |
|---|---|---|
| Operating Cash Flow | $108M | $77M |
| Free Cash Flow | $77M | $74M |
| Capital Spending | -$31M | -$3M |
| OCF Growth YoY | -40.5% | – |
| FCF Growth YoY | -48.8% | – |
| FCF/Sales | 1.6% | 3.0% |
| CapEx/Sales | 0.6% | 0.1% |
Operational Efficiency
| Metric | ALHC | CLOV |
|---|---|---|
| Asset Turnover | 3.81x | 3.44x |
| Receivables Turnover | 20.4x | – |
| Fixed Assets Turnover | 74.4x | 342.5x |
| Days Sales Outstanding | 18 days | – |
Income Statement
| Metric | ALHC | CLOV |
|---|---|---|
| Total Revenue | $4.94B | $2.48B |
| Operating Income | $44M | -$18M |
| SG&A Expense | $514M | – |
Dividend & Shareholder Information
| Metric | ALHC | CLOV |
|---|---|---|
| Shares Outstanding | 207M | 531M |
ALHC vs CLOV: stock comparison and AI forecast
Which is bigger, ALHC or CLOV?
CLOV is 1.6 times larger than ALHC by market capitalization ($2.29B against $1.45B).
Which stock performed better over the last six months, ALHC or CLOV?
Over the last six months CLOV returned +62.6% and ALHC -63.7%.
Which one does Intratio's AI model rank higher, ALHC or CLOV?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.